SK
Sahil Kumar
About Sahil Kumar
Data last updated:
Sahil Kumar is a Director at Peter & Walse Medicaments Private Limited (since 2022). The company operates in Business Services. Peter & Walse Medicaments Private Limited reported revenue of ₹75.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Peter & Walse Medicaments Private Limited U74999BR2017PTC036111 | Director | 24 Mar 2022 | 2017 | ₹75.2 Lakh (FY 2025) | Active |
Board colleagues of Sahil Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sheela Jaiswal | 07961853 | Peter & Walse Medicaments Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sahil Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sahil Kumar
Sahil Kumar currently holds 1 directorship: Peter & Walse Medicaments Private Limited (Director, since 24 Mar 2022, revenue ₹75.2 Lakh (FY 2025)).
Sahil Kumar was first appointed on 24 Mar 2022 as Director at Peter & Walse Medicaments Private Limited.
The current boards of Sahil Kumar's companies include Sheela Jaiswal (Peter & Walse Medicaments Private Limited).